Follow-up of patients with hepatitis non-A, non-B: incidence and persistence of anti-HCV depend on route of transmission.
Of 32 patients with non-A, non-B hepatitis, 10 (31%) were still anti-HCV-positive 12.8 years after the acute phase of the disease. Seven of the patients (21.9%) still had elevated ALT levels, and among these, 5 out of 5 patients who had been subject to parenteral risk were anti-HCV-positive. In contrast, none of the patients who had not been subject to parenteral risks were positive.
Gmelin
K
K
Department of Internal Medicine, University of Heidelberg, Federal Republic of Germany.
Kurzen
F
F
Kallinowski
B
B
Goeser
T
T
Arnold
J
J
Kommerell
B
B
Theilmann
L
L
D005500:Follow-Up Studies; D005858:Germany / Q000453:epidemiology; D006508:Hepatitis Antibodies / Q000097:blood*; D006526:Hepatitis C / Q000209:etiology* / Q000276:immunology / Q000635:transmission; D006521:Hepatitis, Chronic / Q000209:etiology*; D006801:Humans; D015994:Incidence; D007263:Infusions, Parenteral / Q000009:adverse effects*
D006508:Hepatitis Antibodies